{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":85,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":85,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"3276d03249a7","filters":{"venue":"Inpharma Weekly"}},"results":[{"id":"W4249598482","doi":"10.1007/bf03272663","title":"Atorvastatin calcium approved in Canada for MI prevention","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Pharmacy; Pharmacology; Internal medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01454379219708397,"gpt":0.2792005168786046,"spread":0.2646567246815206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000257946,0.0001021488,0.00007413496,0.00003000164,0.00003099736,0.000007539823,0.0001128198,0.00005256208,0.00002485596],"category_scores_gemma":[0.00005659463,0.0001158804,0.00005079395,0.00004622936,0.00001623647,0.000003560863,0.00003176654,0.00005074095,0.000004000575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001004218,"about_ca_system_score_gemma":0.0007239748,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03575664,"about_ca_topic_score_gemma":0.5832056,"domain_scores_codex":[0.9991577,0.00002900068,0.0002220823,0.0002109169,0.00009871025,0.0002816392],"domain_scores_gemma":[0.9996116,0.00001355166,0.00006287739,0.0001552814,0.00005554421,0.0001012169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001707076,0.0001641062,0.05747049,0.0001820025,0.0000765271,0.0002383439,0.0001193013,0.0001788193,0.867383,0.0001166054,0.05832446,0.01403927],"study_design_scores_gemma":[0.00469394,0.00014105,0.4036596,0.00003046598,0.00003564137,0.00001085321,0.0006474419,0.0005760939,0.4894088,0.0001847962,0.09999935,0.000611952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932328,0.00007037674,0.005403745,0.00008640095,0.0002415538,0.0003634313,0.00004351514,0.000006684426,0.0005514221],"genre_scores_gemma":[0.9980819,0.000002557478,0.0005860837,0.0004180274,0.0001758168,0.00002453476,0.0001260576,0.00002027726,0.0005647999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5474489,"threshold_uncertainty_score":0.9706643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239531242","doi":"10.2165/00128413-200414290-00064","title":"The Therapeutic Products Directorate of Health Canada has approved gemifloxacin","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Gemifloxacin; Medicine; Pharmacy; Environmental health; Family medicine; Moxifloxacin; Microbiology; Antibiotics","retraction":null,"screen_n_in":null,"score":{"opus":0.3939423323082523,"gpt":0.4025350128563726,"spread":0.008592680548120346,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0112668,0.0001972142,0.000819628,0.0001005147,0.0004741017,0.00008241181,0.0004289999,0.00005770151,0.00005279894],"category_scores_gemma":[0.001103723,0.000193575,0.00006902656,0.0003069881,0.0001344228,0.0002214138,0.00004330976,0.0001997349,0.0002040213],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001157162,"about_ca_system_score_gemma":0.002857465,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.424143,"about_ca_topic_score_gemma":0.1550162,"domain_scores_codex":[0.9951388,0.0003551455,0.003378758,0.0004522729,0.0001423623,0.0005327095],"domain_scores_gemma":[0.9962018,0.0004760353,0.002430217,0.0006291762,0.000114163,0.000148681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001693136,0.0007658112,0.03063831,0.002987363,0.001021796,0.000007518165,0.01273908,0.005083398,0.0006498311,0.2523075,0.6790197,0.01461034],"study_design_scores_gemma":[0.001939112,0.000137546,0.03021706,0.0001044073,0.00000918101,0.000007466552,0.001261613,0.0007201102,0.0007590903,0.01540892,0.9489218,0.0005136715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2529716,0.02615197,0.00142968,0.7121821,0.002745358,0.00183257,0.0003762354,0.00008796182,0.002222497],"genre_scores_gemma":[0.9831215,0.0002585631,0.0004435951,0.01516136,0.0002554436,0.00008773315,0.00001876813,0.00003768456,0.0006153422],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7301499,"threshold_uncertainty_score":0.8604026,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252046852","doi":"10.2165/00128413-200715940-00063","title":"Health Canada has issued a Qualifying Notice for the approval of dronabinol/cannabidiol","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cannabidiol; Dronabinol; Medicine; Notice; Pharmacy; Cannabis; Family medicine; Psychiatry; Law; Internal medicine; Cannabinoid; Political science","retraction":null,"screen_n_in":null,"score":{"opus":0.05891339858623662,"gpt":0.3702996354452724,"spread":0.3113862368590358,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00194826,0.0001959046,0.0004659859,0.0001179559,0.0003099798,0.00003054657,0.0002830753,0.00007331691,0.000107026],"category_scores_gemma":[0.0003344026,0.0001409769,0.000165434,0.0003951461,0.0002042836,0.0000528105,0.00007046924,0.0003734286,0.000004221354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004379476,"about_ca_system_score_gemma":0.004159797,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4014521,"about_ca_topic_score_gemma":0.1963045,"domain_scores_codex":[0.9973972,0.00006363932,0.000614078,0.0003151868,0.0008186582,0.0007912344],"domain_scores_gemma":[0.9984117,0.000142345,0.0002027762,0.0004424145,0.0004217098,0.0003790351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001179286,0.000185949,0.001393713,0.0009469082,0.0001684914,0.00004303486,0.001202114,0.00003221281,0.005834623,0.0003265901,0.8994068,0.08928028],"study_design_scores_gemma":[0.002954607,0.000517859,0.02527292,0.00008442398,0.00007621285,0.00008687183,0.002210754,0.0008775776,0.0128678,0.00001887594,0.9548382,0.0001939179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.396901,0.008242351,0.007753097,0.5779463,0.001534554,0.005245136,0.0002286276,0.0001075297,0.002041373],"genre_scores_gemma":[0.9800156,0.00004899017,0.000487109,0.005499778,0.0006825511,0.0001204019,0.0000274345,0.00005477701,0.0130634],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5831145,"threshold_uncertainty_score":0.8183609,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230288979","doi":"10.2165/00128413-200816200-00047","title":"New warnings for Alertec in Canada","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Risk and Safety Analysis","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.117417564449509,"gpt":0.3544687148965894,"spread":0.2370511504470804,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000635549,0.0001117431,0.000295951,0.0001967908,0.0001418492,0.00003170002,0.0006272406,0.00003568826,0.0009582023],"category_scores_gemma":[0.0007128944,0.00008835133,0.0001216189,0.0008614751,0.00002635603,0.0002120623,0.00004993227,0.000123453,0.0001675628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001618154,"about_ca_system_score_gemma":0.001709512,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8370749,"about_ca_topic_score_gemma":0.8621667,"domain_scores_codex":[0.9979014,0.00006703579,0.0005391257,0.0003458997,0.0008451355,0.0003013855],"domain_scores_gemma":[0.9984576,0.0007859759,0.000134695,0.0003048725,0.000128234,0.0001885871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006108858,0.0000146079,0.08502142,0.000001374295,0.00001790268,0.0000871016,0.000935436,0.0009417409,0.0002800488,0.00003555745,0.7410195,0.1715842],"study_design_scores_gemma":[0.001365602,0.00003598917,0.1247928,0.000007328488,0.00001719546,0.00003155358,0.0007667647,0.02088749,0.0009905508,0.006093312,0.8447172,0.0002941802],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9566159,0.0005524401,0.01531769,0.02233032,0.0006773769,0.0002611007,0.00002991712,0.00003133607,0.00418389],"genre_scores_gemma":[0.9845784,0.0001277364,0.001296465,0.0009978493,0.0001260807,0.00001005672,0.000003243701,0.000008825766,0.01285137],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.17129,"threshold_uncertainty_score":0.9999551,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4250267269","doi":"10.2165/00128413-200112860-00058","title":"Recent approvals in the Canadian market","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02371898196635164,"gpt":0.279133966060813,"spread":0.2554149840944613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003713328,0.00007605385,0.0001077289,0.0001501086,0.00008357682,0.000009102864,0.000138938,0.0009780078,0.00157747],"category_scores_gemma":[0.00005334167,0.00004882873,0.00003039949,0.0003855637,0.00007636039,0.00002410572,0.00001134131,0.001727437,0.0001500556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006648704,"about_ca_system_score_gemma":0.0001535139,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.008265064,"about_ca_topic_score_gemma":0.03454945,"domain_scores_codex":[0.9993302,0.0000487884,0.0001311366,0.0001291646,0.0001022666,0.0002584769],"domain_scores_gemma":[0.9996251,0.00002879048,0.00002018529,0.0002149545,0.00002492408,0.00008600237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003250441,0.0002981137,0.03323697,0.00002967317,0.0001213495,0.004003272,0.0009980198,0.000003167033,0.001031753,0.002295618,0.6615985,0.2960585],"study_design_scores_gemma":[0.0006891439,0.00004942228,0.03536284,0.00002285043,0.00002378367,0.0006003084,0.0001825191,0.00009334672,0.0003089787,0.0001415288,0.9624616,0.00006366045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1421101,0.001659076,0.000005742043,0.4899582,0.0002909179,0.0003795049,0.000002300612,0.00005761478,0.3655365],"genre_scores_gemma":[0.9721356,0.004156379,0.00006398586,0.01829339,0.00009438754,0.00001894214,0.000006749975,0.000008675255,0.00522191],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8300255,"threshold_uncertainty_score":0.9993352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4210528054","doi":"10.2165/00128413-200715730-00068","title":"A pravastatin/aspirin combination therapy [PravASA; Paladin Labs] has been launched in Canada.","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Pravastatin; Aspirin; Pharmacy; Family medicine; Internal medicine; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.03224183768008571,"gpt":0.2847662141551547,"spread":0.252524376475069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001604903,0.0002123484,0.0004390877,0.0001811194,0.00008484432,0.00002675423,0.0001250801,0.00009626847,0.0001896086],"category_scores_gemma":[0.00007220276,0.0001926167,0.0001109863,0.0004967824,0.00004461667,0.00009917759,0.00002896557,0.0004195777,0.00003084015],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007560376,"about_ca_system_score_gemma":0.002192506,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6435594,"about_ca_topic_score_gemma":0.6165053,"domain_scores_codex":[0.9977127,0.0001168235,0.0004951256,0.0003365325,0.0007869069,0.000551871],"domain_scores_gemma":[0.9989499,0.00007611085,0.0001167545,0.0003995897,0.0001682478,0.0002893309],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001327542,0.0009921669,0.2429142,0.000474907,0.000567572,0.002445228,0.002602743,0.00003145514,0.02698556,0.0004650679,0.0214908,0.6997027],"study_design_scores_gemma":[0.01182447,0.000368452,0.7691893,0.0001535892,0.00004836123,0.0001201196,0.0007331468,0.000206173,0.02517628,0.00009981083,0.1917248,0.0003554518],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887981,0.001411361,0.0003522297,0.005461346,0.0002831397,0.001095625,0.00001472811,0.00005865875,0.002524833],"genre_scores_gemma":[0.9952214,0.0002246182,0.0003439061,0.003272739,0.0002685129,0.00004540371,0.00006864646,0.00004279162,0.000512025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6993473,"threshold_uncertainty_score":0.7854681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231537586","doi":"10.2165/00128413-200615510-00066","title":"Health Canada has approved rituximab [Rituxan; Roche] as a maintenance therapy for patients with follicular non-Hodgkin's lymphoma","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Rituximab; Follicular lymphoma; Oncology; Lymphoma; Hodgkin lymphoma; Maintenance therapy; Internal medicine; Pharmacy; Family medicine; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.007872528325920655,"gpt":0.2359594050837431,"spread":0.2280868767578225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001180758,0.0004033574,0.0007010312,0.00007512703,0.0002764747,0.00006329269,0.0001504808,0.00007684928,0.00003263398],"category_scores_gemma":[0.00001939046,0.0002869378,0.0001601057,0.0002232092,0.00007462569,0.000102399,0.00002559782,0.00006791065,0.00001866608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001124047,"about_ca_system_score_gemma":0.002384058,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4143664,"about_ca_topic_score_gemma":0.07081407,"domain_scores_codex":[0.9976558,0.00003696792,0.0004352336,0.0005739241,0.0005631758,0.0007349076],"domain_scores_gemma":[0.9986409,0.00008608201,0.0002375718,0.0004297884,0.0002953076,0.0003103663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.006756706,0.01828536,0.265282,0.0003825162,0.001082298,0.0005940069,0.0003360211,0.00002978331,0.0003340501,0.0003673566,0.576034,0.1305159],"study_design_scores_gemma":[0.1144319,0.003714197,0.4590398,0.0002973641,0.0001529007,0.00008453343,0.00008984589,0.0003137593,0.005378974,0.0001256381,0.4157976,0.0005734484],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776929,0.001247589,0.0002686256,0.01622381,0.0002721245,0.003225157,0.0001928016,0.00008597828,0.0007910046],"genre_scores_gemma":[0.9888663,0.00009615144,0.001650345,0.007198731,0.000217078,0.0008183417,0.0003996986,0.00007621392,0.00067712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3435524,"threshold_uncertainty_score":0.9999583,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241551250","doi":"10.2165/00128413-200816220-00084","title":"Frovatriptan [Frova; Teva Neuroscience Canada] has been launched in Canada for the treatment of migraines with or without aura in adults.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Aura; Medicine; Pharmacy; Launched; Family medicine; Psychiatry; Migraine; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.05994279408294232,"gpt":0.2833808924903209,"spread":0.2234380984073786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009121386,0.0002212534,0.0005233143,0.00009136143,0.0001327175,0.000004721325,0.0001477688,0.00002659891,0.00002378427],"category_scores_gemma":[0.0001172589,0.0001189372,0.00004897745,0.0004960192,0.0001632026,0.00004421517,0.0000165351,0.0001126987,2.438909e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005699777,"about_ca_system_score_gemma":0.006396884,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9976659,"about_ca_topic_score_gemma":0.9998912,"domain_scores_codex":[0.9985122,0.00002623998,0.00038586,0.0002993395,0.0003782946,0.0003980694],"domain_scores_gemma":[0.9991938,0.0002137524,0.0001082748,0.0002546046,0.0001236257,0.0001059579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002653133,0.0002945542,0.9191992,0.0001746441,0.00007292361,0.000539997,0.006706959,0.00004466913,0.0007303514,0.000003680483,0.06822935,0.001350573],"study_design_scores_gemma":[0.01270494,0.001960764,0.8084772,0.0002314295,0.0001334198,0.0001503885,0.008682086,0.002814845,0.003271704,0.000002997617,0.1612511,0.0003191111],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868817,0.001133373,0.000008688678,0.01054721,0.00006628923,0.001135616,0.00008061239,0.000009849534,0.0001366583],"genre_scores_gemma":[0.995248,0.0005840686,0.0001514863,0.001368796,0.00009794419,0.00008874976,0.000009236674,0.000019624,0.002432087],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.110722,"threshold_uncertainty_score":0.9992359,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244553985","doi":"10.2165/00128413-200715720-00069","title":"Cangene Corporation's hepatitis B immune globulin [HepaGam] has been granted a Notice of Compliance with condition by Health Canada,","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Hepatitis B immune globulin; Compliance (psychology); Corporation; Pharmacy; Family medicine; Immunology; Chronic hepatitis; Law; Political science; Social psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.03727338411076089,"gpt":0.3000161753463018,"spread":0.2627427912355409,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003977528,0.0002491276,0.0006488569,0.000094455,0.0002553688,0.00001525265,0.0001204787,0.00006283211,0.0001333248],"category_scores_gemma":[0.00008530083,0.0002352704,0.0000486946,0.0004581497,0.0002612658,0.0001220044,0.00003373337,0.0002339655,0.00001840217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006246551,"about_ca_system_score_gemma":0.001262383,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9306219,"about_ca_topic_score_gemma":0.950958,"domain_scores_codex":[0.9977697,0.00007486522,0.0007060804,0.0003121529,0.0006555497,0.0004817131],"domain_scores_gemma":[0.9982662,0.0001246662,0.00049976,0.0002878577,0.0005558745,0.0002655976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00150184,0.0006492184,0.5780791,0.00117472,0.0007944899,0.0007961679,0.00142101,0.00003041527,0.04551422,0.0001682249,0.3581107,0.01175993],"study_design_scores_gemma":[0.004765515,0.001176783,0.8968138,0.0008642647,0.0001800165,0.000148473,0.0001800169,0.0003582735,0.04245058,0.00001592008,0.0526206,0.0004257479],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.970993,0.003664134,0.00464502,0.01584286,0.0004227428,0.00136728,0.00153641,0.0001137836,0.001414743],"genre_scores_gemma":[0.9939005,0.0002945672,0.001372754,0.003118385,0.0001093805,0.00002860847,0.0005541795,0.00003993445,0.0005816789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3187347,"threshold_uncertainty_score":0.959405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252472898","doi":"10.2165/00128413-200213410-00052","title":"Recent product approvals in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.4417186797614878,"gpt":0.3969668101560449,"spread":0.04475186960544286,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005442698,0.0001795463,0.0006997766,0.0002331335,0.00008212489,0.00004249288,0.0003154629,0.00005103305,0.004564805],"category_scores_gemma":[0.001580553,0.0002409149,0.00004855885,0.0003375713,0.00002726365,0.0003346889,0.00004266404,0.0002276727,0.003134151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002133506,"about_ca_system_score_gemma":0.0003918422,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5472576,"about_ca_topic_score_gemma":0.4308057,"domain_scores_codex":[0.9955932,0.0002122985,0.00298114,0.0005842052,0.0001107724,0.0005183659],"domain_scores_gemma":[0.9980611,0.0002877304,0.0009409406,0.0004768579,0.00004505515,0.0001882708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009845749,0.0001783369,0.1329416,0.0002254448,0.00004854942,0.0000162421,0.001333327,0.0005013404,0.00001119212,0.005439276,0.8486754,0.01061942],"study_design_scores_gemma":[0.0009147279,0.00002030324,0.03167738,0.00003566562,0.000002478511,0.000009841606,0.0004515963,0.008823627,0.00004157899,0.001240251,0.9563792,0.0004033088],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6502373,0.02033089,0.00009282116,0.2757141,0.00287486,0.001557182,0.0003150039,0.00008504109,0.04879291],"genre_scores_gemma":[0.9720256,0.001461249,0.0005895476,0.0225488,0.0005138249,0.0001631783,0.00001759064,0.00004246378,0.00263776],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3217883,"threshold_uncertainty_score":0.997642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243923408","doi":"10.2165/00128413-200113150-00052","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02023096354187482,"gpt":0.2872669464453149,"spread":0.2670359829034401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009303779,0.00006200515,0.00008257804,0.00001476434,0.0005768953,0.00003930945,0.0001263484,0.00003059873,0.004470489],"category_scores_gemma":[0.00004936588,0.00005548634,0.00003320683,0.0001857351,0.00008438156,0.00009731181,0.00003087503,0.00006919883,0.00003505062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001404734,"about_ca_system_score_gemma":0.0004369036,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9844975,"about_ca_topic_score_gemma":0.9883373,"domain_scores_codex":[0.9991979,0.00007015377,0.0001045387,0.0001240903,0.0002692686,0.0002340529],"domain_scores_gemma":[0.9996107,0.00009307661,0.00003209422,0.00009361375,0.00004979712,0.0001207368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001087037,0.00001447549,0.01863245,7.950163e-7,0.00002514902,0.00007492799,0.001599221,0.000005396386,0.00003037807,0.0006955842,0.9695438,0.009367026],"study_design_scores_gemma":[0.0001434182,0.0000032747,0.03073616,0.000002955601,0.000009798875,7.237895e-7,0.002865239,0.00002162441,0.000008693954,0.0002861652,0.9658397,0.00008228543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.2992137,0.0004612325,0.00001959748,0.04643136,0.001327483,0.0001251128,0.00004696603,0.00005681752,0.6523178],"genre_scores_gemma":[0.969204,0.0002571795,0.00006831199,0.001495505,0.001081809,0.000006430618,0.000005280822,0.000005970487,0.02787552],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6699903,"threshold_uncertainty_score":0.9964396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247698475","doi":"10.2165/00128413-200615670-00056","title":"Health Canada updates information about Tamiflu","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Health information; Medical emergency; Environmental health; Family medicine; Health care; Economic growth","retraction":null,"screen_n_in":null,"score":{"opus":0.1286754122059632,"gpt":0.3766125392026163,"spread":0.2479371269966532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00517687,0.0001916286,0.0006965942,0.0002391353,0.000267135,0.0001275914,0.0002757421,0.00007816273,0.0006327571],"category_scores_gemma":[0.0004242832,0.0002554714,0.00006835386,0.0002141742,0.00003650789,0.001165477,0.00003987263,0.0001739646,0.002670183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001345064,"about_ca_system_score_gemma":0.0009674127,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7785184,"about_ca_topic_score_gemma":0.2875294,"domain_scores_codex":[0.995021,0.0001495386,0.003869411,0.0002938007,0.0001339875,0.0005322273],"domain_scores_gemma":[0.9970464,0.0002461149,0.002067545,0.000364315,0.00007326351,0.0002024178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005172701,0.00002951347,0.02375712,0.0001913501,0.00001941376,7.432982e-7,0.0002879238,0.0004320676,9.93472e-7,0.04532726,0.929329,0.0006194494],"study_design_scores_gemma":[0.0006535577,0.00002493537,0.08392541,0.00003068949,0.000001871951,0.000006131456,0.0002631794,0.002665429,0.00001216884,0.003311081,0.9088257,0.000279852],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3740215,0.008739797,0.007734822,0.5402901,0.004908249,0.002113841,0.003559085,0.0003687947,0.05826388],"genre_scores_gemma":[0.9228606,0.000104295,0.001143136,0.07344165,0.0006499029,0.00008338465,0.0004889356,0.00002922566,0.001198899],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5488391,"threshold_uncertainty_score":0.9999897,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248864116","doi":"10.2165/00128413-200816340-00055","title":"Health Canada issues foreign product alert","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Product (mathematics); Medical emergency; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05127717373382897,"gpt":0.3116325408963768,"spread":0.2603553671625479,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005300528,0.0001943255,0.0003920229,0.0001015595,0.0004456917,0.00003637971,0.000306516,0.00003927179,0.000284667],"category_scores_gemma":[0.0002599606,0.0001723337,0.00005107798,0.0003772684,0.00007228606,0.0004724823,0.0001278536,0.0001817192,0.0002753505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001450513,"about_ca_system_score_gemma":0.0005768234,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.962603,"about_ca_topic_score_gemma":0.2466484,"domain_scores_codex":[0.9980415,0.00003410524,0.0004811164,0.000322463,0.0002564769,0.0008643945],"domain_scores_gemma":[0.999227,0.0000386478,0.0002414035,0.0002752944,0.0001461404,0.0000715499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000008779272,0.00002385547,0.009809329,0.0001158569,0.000010897,0.00002134193,0.00001590591,0.0001075946,0.000005046918,0.006033675,0.9820427,0.001805055],"study_design_scores_gemma":[0.0002598472,0.00000985326,0.02123654,0.00001215726,0.000003756927,0.00002826506,0.00008594606,0.0009497339,0.000004508994,0.0003980389,0.9768428,0.0001685996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1756721,0.001840244,0.00003902815,0.7337944,0.001918121,0.0006011946,0.00001765372,0.0002843577,0.08583295],"genre_scores_gemma":[0.745074,0.0002100798,0.0001047733,0.2494506,0.003740911,0.00002387409,0.00004523733,0.00002526121,0.001325247],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.7159546,"threshold_uncertainty_score":0.7670983,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239700607","doi":"10.2165/00128413-200816490-00061","title":"Idebenone approved in Canada, but EU needs more data","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Idebenone; Family medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.5159014374493767,"gpt":0.4176488603409993,"spread":0.09825257710837737,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005158581,0.0002413771,0.0009487452,0.0004234714,0.0001691209,0.00003566085,0.001000385,0.0001056094,0.0006630537],"category_scores_gemma":[0.00137257,0.0003291485,0.00005179097,0.0004357127,0.00007773301,0.0007655149,0.0002250054,0.0003167552,0.001193638],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001402926,"about_ca_system_score_gemma":0.001738216,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8734229,"about_ca_topic_score_gemma":0.5139825,"domain_scores_codex":[0.995012,0.0001783308,0.003375273,0.0006681233,0.000152187,0.0006140575],"domain_scores_gemma":[0.9968176,0.0005145214,0.001093919,0.001250489,0.00004524387,0.0002782166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003645189,0.00016726,0.2393852,0.0002528136,0.0001006884,0.00006642313,0.002718995,0.0006225645,0.0000343478,0.004974738,0.7512119,0.0004285223],"study_design_scores_gemma":[0.003451844,0.00004728413,0.2699639,0.0000838113,0.00001129743,0.00009301169,0.00536707,0.07711944,0.00004283577,0.0009983988,0.6416643,0.001156876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8864377,0.00295382,0.0009460925,0.09543829,0.001298096,0.0008489478,0.002160049,0.00007063602,0.00984638],"genre_scores_gemma":[0.9667018,0.0002318004,0.0008767248,0.02945853,0.0004567728,0.00006901443,0.0002693763,0.00005215325,0.001883834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3594404,"threshold_uncertainty_score":0.9999161,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233022709","doi":"10.2165/00128413-200615320-00042","title":"Health Canada has warned consumers about counterfeit and unapproved products for avian influenza.","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Counterfeit; Medicine; Influenza A virus subtype H5N1; Pharmacy; Virology; Advertising; Environmental health; Commerce; Business; Family medicine; Virus; Political science; Law","retraction":null,"screen_n_in":null,"score":{"opus":0.04094740791769242,"gpt":0.2938180971714604,"spread":0.252870689253768,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008012693,0.0002424356,0.0004540911,0.0001113382,0.0004617935,0.0001936951,0.0002004664,0.00007524842,0.00002221835],"category_scores_gemma":[0.0003257669,0.0002269816,0.00003818301,0.0002819723,0.0001412351,0.0004207278,0.00009271165,0.0001530465,0.00002104196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001671525,"about_ca_system_score_gemma":0.0007125938,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9334025,"about_ca_topic_score_gemma":0.4085808,"domain_scores_codex":[0.9978484,0.00003145893,0.0006228543,0.0004149702,0.0001700287,0.0009122966],"domain_scores_gemma":[0.998959,0.0001091163,0.0003911484,0.0002160297,0.0002625765,0.00006213767],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005352543,0.00002970267,0.009489855,0.0006633446,0.00002113368,0.000002485172,0.00001563349,0.0001026416,0.00004664098,0.004905809,0.9825506,0.002118662],"study_design_scores_gemma":[0.001144268,0.00001748543,0.02488377,0.00002921082,0.00001720086,0.000004569318,0.00008817234,0.003314952,0.000007187803,0.0004498452,0.9698226,0.0002207164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4514031,0.002121866,0.0001222253,0.5362858,0.001901936,0.00189056,0.0001401933,0.0002138402,0.005920582],"genre_scores_gemma":[0.8125605,0.00002791926,0.0001493496,0.1852328,0.001437754,0.00008989362,0.0001260758,0.00003567488,0.0003400565],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5248218,"threshold_uncertainty_score":0.9256041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233820458","doi":"10.2165/00128413-200514910-00055","title":"The Therapeutic Products Directorate of Canada has issued a Notice of Compliance for metformin","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Notice; Medicine; Metformin; Compliance (psychology); Pharmacy; Intensive care medicine; Family medicine; Diabetes mellitus; Law; Political science; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.5281201482468323,"gpt":0.440615957599408,"spread":0.08750419064742432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007393465,0.0001490784,0.0006945212,0.00007908565,0.0002317617,0.00003402151,0.000403498,0.00005057305,0.00007150431],"category_scores_gemma":[0.00177504,0.0001477467,0.00007547426,0.0002042035,0.0001187982,0.0002396246,0.0000285179,0.00009705922,0.00005446948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003294515,"about_ca_system_score_gemma":0.0007419706,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03808265,"about_ca_topic_score_gemma":0.04003468,"domain_scores_codex":[0.9964289,0.0001373469,0.002655331,0.0003058678,0.000105523,0.0003670137],"domain_scores_gemma":[0.9956317,0.001443766,0.002127994,0.0004668177,0.0002439075,0.00008583441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007786158,0.0009038134,0.01778156,0.007412255,0.001605848,0.000002109929,0.01091174,0.004939221,0.002971139,0.1965453,0.7315086,0.0246397],"study_design_scores_gemma":[0.001175948,0.00008569533,0.005826553,0.00008673136,0.00001993466,0.000002871305,0.0005096643,0.01520642,0.005144101,0.002125884,0.9695288,0.0002874133],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4500729,0.04407127,0.004511854,0.4835871,0.003620048,0.005323649,0.002211165,0.00008348384,0.006518451],"genre_scores_gemma":[0.9910614,0.00009556548,0.002587312,0.00367465,0.0003442451,0.0001310591,0.00001074585,0.00002919557,0.002065759],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5409885,"threshold_uncertainty_score":0.9774822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236537247","doi":"10.2165/00128413-200313780-00008","title":"Statin therapy cost saving for prevention of CVD in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Intensive care medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03379908012347198,"gpt":0.3110744887768535,"spread":0.2772754086533815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000427363,0.00007137804,0.0002332419,0.0000437184,0.00002122491,0.000002827286,0.00003393385,0.00002500899,0.00009165971],"category_scores_gemma":[0.000061271,0.00006337949,0.00008525602,0.0001210929,0.000008822713,0.0000338368,0.000003727245,0.00008161207,0.000001003971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002377284,"about_ca_system_score_gemma":0.001225534,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3634537,"about_ca_topic_score_gemma":0.2309838,"domain_scores_codex":[0.9991562,0.00007223721,0.0002437934,0.000122173,0.0002243456,0.0001812129],"domain_scores_gemma":[0.9996044,0.00003570303,0.00006546158,0.0001562461,0.00006921504,0.00006896937],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006710823,0.0004311844,0.06728333,0.0009397321,0.0003431935,0.00006526834,0.0006048677,0.0001347575,0.03290577,0.0008803586,0.007947645,0.8877928],"study_design_scores_gemma":[0.03023834,0.001082756,0.3204204,0.0006412113,0.00014432,0.0001005122,0.002258258,0.0005555141,0.2787191,0.0006453095,0.3646886,0.000505624],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945625,0.001421838,0.001261184,0.0003110466,0.0001614508,0.001370892,0.00001739894,0.000007142828,0.0008865275],"genre_scores_gemma":[0.9980907,0.0002141389,0.0009453967,0.0003679356,0.00005264428,0.0001111989,0.00001347181,0.00001448883,0.000190019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8872872,"threshold_uncertainty_score":0.7830487,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4253209358","doi":"10.2165/00128413-200213670-00012","title":"COX-2 inhibitor use increased after formulary listing in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Listing (finance); Pharmacy; Family medicine; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.01691755257048687,"gpt":0.220593493756027,"spread":0.2036759411855401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001804269,0.0001957673,0.0003071159,0.0001299654,0.00004437879,0.00002093103,0.00006848622,0.0000740232,0.0008350591],"category_scores_gemma":[0.0002430073,0.0001794721,0.00005821873,0.0002175787,0.00002631364,0.0002131034,0.0000408888,0.0003369797,0.00009799363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005105296,"about_ca_system_score_gemma":0.0003574876,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4466174,"about_ca_topic_score_gemma":0.3216841,"domain_scores_codex":[0.9985543,0.00006757736,0.0003509854,0.0002365128,0.0003506218,0.0004399882],"domain_scores_gemma":[0.9991599,0.0001790875,0.00006736744,0.0002324055,0.00005896719,0.0003022757],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004129567,0.0001395309,0.9349154,0.0002773607,0.00003781033,0.007951808,0.0004818559,0.000007227341,0.007915202,0.000005580137,0.04245549,0.005399767],"study_design_scores_gemma":[0.009918575,0.0002429884,0.8321705,0.0008139716,0.0001360601,0.0002908817,0.0001578313,0.01673991,0.02625604,0.000008126306,0.1124617,0.0008034385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974751,0.0004708353,0.000003377655,0.0003293037,0.0004784284,0.0003876663,0.00001984286,0.00004652491,0.0007889126],"genre_scores_gemma":[0.9952818,0.00001728219,0.0001062785,0.003649688,0.000508588,0.00006391816,0.00001184244,0.00003637287,0.0003242631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1249333,"threshold_uncertainty_score":0.9143311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4237317969","doi":"10.2165/00128413-200213670-00047","title":"Market news from Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.0267519930970027,"gpt":0.2678704925917876,"spread":0.2411184994947849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000665671,0.00006146541,0.00008131589,0.00001395869,0.0005741772,0.00003936506,0.0001236599,0.00003032799,0.01255289],"category_scores_gemma":[0.00005066533,0.00005526212,0.00003382777,0.0001524499,0.00008855228,0.00009347554,0.00002832359,0.00007191754,0.0000751254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001250851,"about_ca_system_score_gemma":0.0001237904,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9656278,"about_ca_topic_score_gemma":0.9684946,"domain_scores_codex":[0.9992121,0.00006997543,0.0001030404,0.0001224058,0.0002714384,0.0002209787],"domain_scores_gemma":[0.9996223,0.00009448114,0.00003178871,0.00009425537,0.00004128831,0.0001158441],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000001796127,0.0000121181,0.002676031,7.842115e-7,0.00001683493,0.00002287937,0.001993034,0.000002500021,0.00001432989,0.0004068407,0.9877154,0.007137404],"study_design_scores_gemma":[0.0001374439,0.000003373882,0.008251695,0.000002888696,0.000009964265,3.062134e-7,0.002051863,0.0001008535,0.00001104137,0.0001383332,0.9892069,0.00008536714],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1102332,0.001065586,0.000008320846,0.05751853,0.001442517,0.0001352835,0.00007788816,0.00006305167,0.8294556],"genre_scores_gemma":[0.9598615,0.0002107464,0.00007033358,0.001410975,0.0008900875,0.000006146878,0.000002565675,0.000005818948,0.0375418],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8496283,"threshold_uncertainty_score":0.9883498,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230932386","doi":"10.2165/00128413-200715990-00047","title":"Health Canada has granted expanded approval of lumiracoxib [Prexige; Novartis] for the treatment of acute and chronic osteoarthritis","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Pharmacy; Alternative medicine; Physical therapy; Intensive care medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.01777054040401422,"gpt":0.2917364214198742,"spread":0.2739658810158599,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003549894,0.0001733346,0.0004971477,0.00006677816,0.00012187,0.000005680091,0.00006376172,0.00005425367,0.00002079613],"category_scores_gemma":[0.00001931837,0.0001187266,0.0000975451,0.0001348797,0.0001715516,0.0000360843,0.00001182484,0.00007800208,6.655749e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002375651,"about_ca_system_score_gemma":0.00110442,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03609322,"about_ca_topic_score_gemma":0.1140633,"domain_scores_codex":[0.998691,0.00003164137,0.0004605188,0.0001902231,0.0002568038,0.0003698694],"domain_scores_gemma":[0.9990129,0.0002534083,0.0002153615,0.0002300479,0.0001086387,0.0001795721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.006021539,0.0008950658,0.01006244,0.002222728,0.001516084,0.0003639,0.005105261,0.0000162784,0.203005,0.0001226075,0.01925529,0.7514138],"study_design_scores_gemma":[0.03118721,0.01378213,0.03664337,0.0004225593,0.0007772549,0.0003645301,0.0005576571,0.001105973,0.8428256,0.00002319453,0.07195442,0.0003560836],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890147,0.00619989,0.0005998177,0.001797669,0.0004326924,0.001746583,0.0001333624,0.0000194363,0.00005587039],"genre_scores_gemma":[0.9984612,0.0005587205,0.000163902,0.0002419052,0.0002909806,0.00007085668,0.00003367007,0.00002404587,0.000154667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7510577,"threshold_uncertainty_score":0.9703255,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234132940","doi":"10.2165/00128413-200716130-00053","title":"Biovail has launched a once-daily tramadol formulation [Ralivia] in Canada for the management of moderately severe pain","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Tramadol; Medicine; Launched; Pharmacy; Physical therapy; Anesthesia; Family medicine; Analgesic; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.06399885725976563,"gpt":0.2792984534208143,"spread":0.2152995961610487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004861038,0.0001789012,0.000183981,0.0001078667,0.0001498632,0.00005229918,0.0003685514,0.00003890835,0.00004138616],"category_scores_gemma":[0.0001802443,0.0001422103,0.00007275558,0.0004444628,0.00002842208,0.0001773725,0.00005378651,0.0001273964,0.000007395879],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002319858,"about_ca_system_score_gemma":0.0001221369,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06250785,"about_ca_topic_score_gemma":0.1837567,"domain_scores_codex":[0.9980848,0.0003957927,0.0003811721,0.0003099841,0.0003889403,0.0004393016],"domain_scores_gemma":[0.9974161,0.002131623,0.0001212497,0.0002468066,0.00002810361,0.00005610362],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.005764823,0.0006412506,0.01748401,0.002772026,0.0004144927,0.0006129029,0.003569315,0.09815605,0.1035271,0.00820691,0.06853472,0.6903164],"study_design_scores_gemma":[0.003358469,0.0001037488,0.01691794,0.0001346627,0.00008029409,0.000003739895,0.0009816546,0.9309109,0.02714973,0.000800777,0.0191124,0.0004456259],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8668673,0.0001445996,0.1230485,0.002728271,0.0005007319,0.003325572,0.00005024279,0.00006891762,0.003265924],"genre_scores_gemma":[0.9976364,0.00002910177,0.0002934707,0.001273445,0.00004238747,0.00004408574,0.000007694553,0.00001895795,0.0006544318],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8327549,"threshold_uncertainty_score":0.943735,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255619675","doi":"10.2165/00128413-200112960-00010","title":"Antipsychotic polypharmacy in schizophrenia in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Polypharmacy; Medicine; Antipsychotic; Schizophrenia (object-oriented programming); Psychiatry; Pharmacy; Pharmacology; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02528746022205306,"gpt":0.3087349721650757,"spread":0.2834475119430226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001515886,0.0001994199,0.0003268997,0.0003664621,0.00003211025,0.00001712415,0.0001485003,0.00003824108,0.0009193186],"category_scores_gemma":[0.00004872239,0.0001783426,0.0000535105,0.0008060015,0.00003203842,0.0001108912,0.00003660364,0.0004372953,0.0001637512],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009454919,"about_ca_system_score_gemma":0.002460142,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7333208,"about_ca_topic_score_gemma":0.892554,"domain_scores_codex":[0.9981425,0.00007104372,0.00035338,0.0003398352,0.0004597363,0.0006335438],"domain_scores_gemma":[0.9991989,0.00007675112,0.00003867909,0.0002755778,0.00003796621,0.0003720934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01766971,0.0005336639,0.8928153,0.0000402532,0.00006458855,0.01485058,0.00005955739,0.00002441011,0.002425568,0.00007369478,0.004275825,0.06716688],"study_design_scores_gemma":[0.02332741,0.0001120663,0.9695301,0.0001235687,0.00002092879,0.0004304858,0.00009589823,0.0009298418,0.00182944,0.0001566646,0.003248463,0.0001951422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895819,0.001173918,0.000002454554,0.006402539,0.0002306677,0.000503024,0.000009770869,0.00003039402,0.002065287],"genre_scores_gemma":[0.9977389,0.0005027988,0.0003129213,0.0008225423,0.0001319082,0.00005444164,0.00001933094,0.00002697527,0.0003901974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1592332,"threshold_uncertainty_score":0.999994,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4238567827","doi":"10.2165/00128413-200514860-00055","title":"Nicotinic acid [niacin] extended-release tablets [Niaspan] have been launched in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Niacin; Medicine; Launched; Pharmacy; Pharmacology; Nicotinic agonist; Family medicine; Internal medicine; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.04005818013570484,"gpt":0.3366964691176261,"spread":0.2966382889819212,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003743503,0.0003076265,0.0005385314,0.00008976052,0.0001193116,0.00002833729,0.0002138033,0.00008514946,0.002708736],"category_scores_gemma":[0.0003083964,0.0002678785,0.00009535779,0.000287273,0.00006478964,0.0002831582,0.0001440556,0.0007742103,0.0002944494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007997444,"about_ca_system_score_gemma":0.0009771283,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3528703,"about_ca_topic_score_gemma":0.5719416,"domain_scores_codex":[0.9975395,0.0001185705,0.000552506,0.0004557316,0.0005463441,0.0007874158],"domain_scores_gemma":[0.9986081,0.0002869939,0.0001528621,0.0003193718,0.00009908275,0.0005336182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003205702,0.001836075,0.1547466,0.0004645165,0.000874033,0.00271073,0.001130197,0.0002686662,0.05509494,0.0001380925,0.2720662,0.5074642],"study_design_scores_gemma":[0.005996326,0.0001542362,0.09694763,0.0001100647,0.0002700763,0.0001468271,0.0006852784,0.00327028,0.02223963,0.00003354938,0.8696689,0.0004771704],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9101179,0.008011794,0.00001757326,0.05511764,0.0004735162,0.0006565043,0.0000645527,0.00008681863,0.02545371],"genre_scores_gemma":[0.9823762,0.00108,0.000291667,0.01387934,0.0006039863,0.00004876961,0.00002088218,0.00003851755,0.001660674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5976027,"threshold_uncertainty_score":0.9999774,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233017224","doi":"10.2165/00128413-200213330-00013","title":"Inappropriate pantoprazole use in Canada despite guidelines","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pantoprazole; Pharmacy; Intensive care medicine; Internal medicine; Family medicine; Omeprazole","retraction":null,"screen_n_in":null,"score":{"opus":0.2254775789564057,"gpt":0.3783929247872928,"spread":0.1529153458308871,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002077187,0.0001678058,0.0002899552,0.00005611521,0.00006870543,0.00003000302,0.000104858,0.00004039479,0.001708918],"category_scores_gemma":[0.0004604207,0.000136827,0.00004597221,0.000278648,0.00003211507,0.0002647737,0.00007897954,0.0003378217,0.0001240163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002635773,"about_ca_system_score_gemma":0.0001535838,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6822516,"about_ca_topic_score_gemma":0.5105882,"domain_scores_codex":[0.998543,0.00005533544,0.0004190877,0.000245442,0.0003280699,0.0004091056],"domain_scores_gemma":[0.9991782,0.0001947976,0.00008598144,0.0001866049,0.0001321341,0.0002223208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004743293,0.0003751538,0.4716651,0.0001685486,0.0002387553,0.002306598,0.000378376,0.00009831061,0.006128063,0.0000618503,0.364019,0.1540859],"study_design_scores_gemma":[0.002057801,0.00005696496,0.05668655,0.00006455595,0.00008275107,0.00008227722,0.000177808,0.008557786,0.001429608,0.00001819444,0.9305704,0.0002153573],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9618464,0.003539973,0.00001270248,0.02883489,0.0004320832,0.0003028509,0.00002187264,0.00004141319,0.004967839],"genre_scores_gemma":[0.9825122,0.002627565,0.0005255656,0.01264244,0.000234912,0.00002229471,0.000005264952,0.00002036806,0.001409426],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5665513,"threshold_uncertainty_score":0.9992037,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244333022","doi":"10.2165/00128413-200514710-00050","title":"Berlex has announced the Canadian approval of ethinylestradiol/drospirenone","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Ethinylestradiol; Drospirenone; Pharmacy; Family medicine; Gynecology; Environmental health; Research methodology","retraction":null,"screen_n_in":null,"score":{"opus":0.03238519109358545,"gpt":0.2717984732535745,"spread":0.2394132821599891,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006687121,0.0001881129,0.0003172759,0.0001271527,0.0002416695,0.00003021852,0.0001970921,0.0001535223,0.0002365883],"category_scores_gemma":[0.000150078,0.0001317585,0.0001248864,0.0002326121,0.0003040599,0.00009685662,0.00002058632,0.0004663744,0.0001525035],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001854421,"about_ca_system_score_gemma":0.001020492,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01438539,"about_ca_topic_score_gemma":0.02870024,"domain_scores_codex":[0.9985411,0.00007580544,0.0003359814,0.0002129831,0.0004040745,0.0004300362],"domain_scores_gemma":[0.9988451,0.0000835882,0.0001070686,0.0003806032,0.000190721,0.0003929484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007497648,0.0007348792,0.06343438,0.0009131972,0.0008224181,0.001240947,0.01404749,0.0004269845,0.165621,0.001784806,0.5399999,0.2102243],"study_design_scores_gemma":[0.004671816,0.0005473376,0.1095221,0.0001868844,0.0002994218,0.0003735091,0.0002739763,0.003015077,0.06548008,0.00006260375,0.8150752,0.0004919567],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9731836,0.0003759324,0.00001537338,0.01512704,0.0005892803,0.0005872879,0.00002847165,0.00006059111,0.01003243],"genre_scores_gemma":[0.994747,0.00001688673,0.0003004021,0.00252069,0.0013176,0.00003065081,0.00002292921,0.00003014351,0.001013721],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2750753,"threshold_uncertainty_score":0.9921779,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234456851","doi":"10.2165/00128413-200716160-00066","title":"Health Canada has approved anidulafungin [Eraxis; Pfizer].","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Anidulafungin; Pharmacy; Family medicine; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.02427527801991496,"gpt":0.3019655304416766,"spread":0.2776902524217617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001686945,0.0001928986,0.0003222259,0.00007474497,0.0001454239,0.0000224633,0.00008502843,0.00004227416,0.0002726449],"category_scores_gemma":[0.00002968924,0.0001677149,0.00008916717,0.0002150537,0.00003751706,0.00005585148,0.00002859587,0.0001529814,0.00007409754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004977768,"about_ca_system_score_gemma":0.001537006,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3763563,"about_ca_topic_score_gemma":0.202641,"domain_scores_codex":[0.9984304,0.00002336502,0.0003196726,0.0002849804,0.0003931146,0.0005484084],"domain_scores_gemma":[0.9988207,0.00004795159,0.00008934778,0.0002871751,0.00007064686,0.0006841646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001262627,0.001464902,0.185948,0.0003827384,0.0006080571,0.003290778,0.0002821462,0.000006415626,0.002554386,0.0002835175,0.6674344,0.136482],"study_design_scores_gemma":[0.007952264,0.0005269836,0.4618703,0.0001190297,0.000168443,0.0001960086,0.0002416212,0.0001341499,0.003671401,0.00006006551,0.524715,0.0003446735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9584845,0.004339843,0.0003807754,0.02642068,0.0008923966,0.001064515,0.0001512151,0.0001904164,0.00807564],"genre_scores_gemma":[0.9890114,0.00004685391,0.0004210704,0.007776877,0.0002485663,0.000008093217,0.0001172847,0.00003416731,0.002335652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2759223,"threshold_uncertainty_score":0.8119087,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248803141","doi":"10.2165/00128413-200213480-00012","title":"Amiodarone lowers costs for atrial fibrillation in Canada","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Amiodarone; Atrial fibrillation; Cardiology; Internal medicine; Dronedarone; Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06332727414332998,"gpt":0.3143081856551948,"spread":0.2509809115118649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001266919,0.0001140214,0.0002417218,0.0001115145,0.00004306434,0.00001388672,0.00004614507,0.00003921944,0.000573154],"category_scores_gemma":[0.0001328272,0.0001112219,0.000120445,0.0002084465,0.00001314887,0.0001124698,0.00001834454,0.0000618719,0.0000464681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005932904,"about_ca_system_score_gemma":0.0001265615,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1305974,"about_ca_topic_score_gemma":0.1316087,"domain_scores_codex":[0.9990181,0.00002330611,0.0003107262,0.0001799673,0.0002372677,0.0002305856],"domain_scores_gemma":[0.9994991,0.0001594856,0.00008050534,0.000126364,0.00004612851,0.00008839774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008028054,0.000003891433,0.817778,0.00008953665,0.0001130321,0.00004139781,0.0001253212,0.001899962,0.0007407794,0.0002109601,0.088023,0.09017133],"study_design_scores_gemma":[0.01390389,0.0001958398,0.289199,0.00006969515,0.0001845769,0.00001096608,0.0001989067,0.04579208,0.0005937487,0.00006380428,0.6494039,0.0003836426],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9733213,0.0005424505,0.000200836,0.01923824,0.001240576,0.001372699,0.00002465281,0.00006044449,0.003998758],"genre_scores_gemma":[0.9932991,0.00009485389,0.000307959,0.0004323546,0.001644673,0.000001930847,0.00004070107,0.00001821558,0.00416025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5613809,"threshold_uncertainty_score":0.8842372,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241129018","doi":"10.2165/00128413-200012260-00049","title":"Ropinirole: sudden onset of sleep warning issued in Canada","year":2000,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ropinirole; Medicine; Sleep (system call); Pharmacy; Psychiatry; Internal medicine; Family medicine; Agonist","retraction":null,"screen_n_in":null,"score":{"opus":0.009307827362471868,"gpt":0.2671578414079682,"spread":0.2578500140454963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001150399,0.0001449719,0.0002321701,0.00010908,0.00003544777,0.000005389933,0.0002350813,0.0001086261,0.02396048],"category_scores_gemma":[0.00001423299,0.0001424095,0.00004702398,0.0003308983,0.00004621719,0.00004807557,0.00001665497,0.0003183875,0.0004218436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008764071,"about_ca_system_score_gemma":0.0002077866,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8287892,"about_ca_topic_score_gemma":0.3691896,"domain_scores_codex":[0.9986766,0.000134174,0.0003717535,0.0002470633,0.0001824909,0.0003879012],"domain_scores_gemma":[0.9994664,0.00009345209,0.00007508253,0.0002494159,0.00002195096,0.00009364965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0009205224,0.00077346,0.2733407,0.00004803401,0.0009482534,0.001419768,0.01061312,0.003932679,0.000547978,0.0001373012,0.2326297,0.4746885],"study_design_scores_gemma":[0.02077853,0.0003767725,0.4839159,0.0002177906,0.0003227346,0.0002746734,0.01329868,0.003198896,0.001951693,0.0003318592,0.4736862,0.001646262],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9370669,0.001360029,0.000003080542,0.000985113,0.0006759714,0.0001452352,0.00002001753,0.00002913113,0.05971453],"genre_scores_gemma":[0.9959239,0.00009517502,0.00001975393,0.0006442384,0.00004822836,0.00001704705,0.00001906527,0.00002435031,0.003208253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4730422,"threshold_uncertainty_score":0.9769318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246947765","doi":"10.2165/00128413-200816260-00082","title":"Extended-release bupropion approved for SAD in Canada.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bupropion; Medicine; Pharmacology; Psychiatry; Smoking cessation","retraction":null,"screen_n_in":null,"score":{"opus":0.02646522397901797,"gpt":0.2701920319776858,"spread":0.2437268079986678,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004969566,0.0001390629,0.0002378584,0.00006678846,0.00006583764,0.000003566968,0.00006167116,0.00004159908,0.00004567058],"category_scores_gemma":[0.00007667344,0.0001188489,0.00005344152,0.0001268497,0.00002364609,0.00005297979,0.00001462217,0.0001210735,0.00002169025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000533461,"about_ca_system_score_gemma":0.001176207,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4345801,"about_ca_topic_score_gemma":0.1314897,"domain_scores_codex":[0.9990449,0.00001807723,0.0002059584,0.000227181,0.0001927369,0.0003111652],"domain_scores_gemma":[0.9995067,0.00005282264,0.0000471467,0.0001784104,0.00004671791,0.0001682382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006180863,0.002422383,0.4875098,0.0005506398,0.000455772,0.005524388,0.001572425,0.00009947646,0.02939955,0.0001572836,0.3025079,0.1636195],"study_design_scores_gemma":[0.01849974,0.000518759,0.8866219,0.0002111389,0.0001364693,0.0004252294,0.0002803695,0.004265391,0.02481102,0.0000682578,0.06372982,0.0004318831],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960518,0.0003563309,0.00007757192,0.001257274,0.0002384134,0.0005154131,0.00003044685,0.00004488012,0.001427818],"genre_scores_gemma":[0.9947278,0.00006167895,0.0005335134,0.001090721,0.0001161867,0.00008774093,0.00004641366,0.00002383101,0.003312091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3991122,"threshold_uncertainty_score":0.8843584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4256035456","doi":"10.2165/00128413-200715930-00041","title":"New Avastin safety info issued in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Traditional medicine; Family medicine; Optometry; Ophthalmology","retraction":null,"screen_n_in":null,"score":{"opus":0.01439087432189298,"gpt":0.3084827949802439,"spread":0.294091920658351,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000162303,0.0001401201,0.0002533486,0.0001060037,0.00002765037,0.000004241416,0.0000752487,0.00004642361,0.005038796],"category_scores_gemma":[0.00001901025,0.0001321094,0.00003962887,0.00027426,0.00001804642,0.00004908177,0.00002605212,0.0002197597,0.00009685231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001216173,"about_ca_system_score_gemma":0.002139391,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8909091,"about_ca_topic_score_gemma":0.9175262,"domain_scores_codex":[0.9989043,0.00001806925,0.0003155456,0.0001809951,0.0002016874,0.0003794379],"domain_scores_gemma":[0.9993807,0.000113482,0.00005164131,0.0001263598,0.00003114702,0.0002966656],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003131635,0.0001981237,0.332806,0.00006177351,0.0001563776,0.003300289,0.0007032252,0.00003521197,0.0168099,0.00006214749,0.4800338,0.1627015],"study_design_scores_gemma":[0.007836393,0.0001494541,0.3427467,0.00003697489,0.00008430519,0.000112954,0.000131585,0.00005005446,0.01676502,0.0000180141,0.6318964,0.0001722015],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9312113,0.001054557,0.0001614551,0.009093858,0.001326692,0.0005194189,0.00001723938,0.00005745917,0.05655804],"genre_scores_gemma":[0.981916,0.00008196009,0.0003770069,0.003868219,0.0005305755,0.000005756198,0.0000273986,0.00001768565,0.01317543],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1625293,"threshold_uncertainty_score":0.9958707,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255149466","doi":"10.2165/00128413-200715780-00050","title":"Health Canada advises of health risks with EMPowerplus","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Environmental health; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04979907539551033,"gpt":0.3510823803909179,"spread":0.3012833049954076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002381895,0.0001977946,0.0005897183,0.0001738138,0.0002502189,0.00002627915,0.0002674747,0.00004884769,0.0001255663],"category_scores_gemma":[0.0001484136,0.0001609507,0.00004446297,0.0005648236,0.00008143978,0.0002822301,0.00009565787,0.0002038841,0.00002548532],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002033284,"about_ca_system_score_gemma":0.001287482,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.983823,"about_ca_topic_score_gemma":0.7031225,"domain_scores_codex":[0.9974374,0.00004815697,0.0008871531,0.0002620621,0.0003210804,0.001044155],"domain_scores_gemma":[0.9984884,0.00012192,0.0008550766,0.000248237,0.0001826969,0.0001036663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006923448,0.00005786036,0.03385388,0.0005010559,0.00002563099,0.00001009776,0.00004912296,0.0003074595,0.000002799434,0.004803175,0.9403443,0.01997534],"study_design_scores_gemma":[0.0005617877,0.0000611551,0.1056116,0.00005640579,0.000005430704,0.000007139985,0.0007266566,0.0002636416,0.000002563071,0.00008504799,0.8924723,0.0001462544],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5644956,0.001886489,0.001676509,0.3892396,0.001844751,0.0009069467,0.00004859931,0.0002025081,0.039699],"genre_scores_gemma":[0.8513342,0.00005179477,0.0001534807,0.1477991,0.0005475868,0.000004684796,0.00002827577,0.00002065316,0.00006026522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2868386,"threshold_uncertainty_score":0.6563377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4247561095","doi":"10.2165/00128413-200313820-00041","title":"A new 20mg formulation of doxycycline hyclate ['Periostat'; CollaGenex Pharmaceuticals] has been approved in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Doxycycline; Pharmacy; Pharmacology; Family medicine; Antibiotics; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.05076536241035398,"gpt":0.3241503845011009,"spread":0.2733850220907469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002057439,0.0002203541,0.0004159331,0.000070485,0.00006434487,0.000015352,0.0001345651,0.0000884987,0.0009590409],"category_scores_gemma":[0.0001338649,0.0002178906,0.00008238019,0.0005650547,0.00005592712,0.00009471169,0.00002423381,0.0003200359,0.00001700328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003770634,"about_ca_system_score_gemma":0.002160877,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04703852,"about_ca_topic_score_gemma":0.01572181,"domain_scores_codex":[0.9982063,0.00005045471,0.0006583967,0.000331494,0.0003469221,0.0004064236],"domain_scores_gemma":[0.9988526,0.0001409355,0.0001363418,0.0002901752,0.00009485336,0.0004850935],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005343879,0.0003321251,0.01999849,0.0002950495,0.0001229376,0.00009421369,0.0001659844,0.0004232637,0.9515175,0.0005493198,0.01663746,0.009329312],"study_design_scores_gemma":[0.006532321,0.00005301764,0.009428086,0.00006805579,0.0001771921,0.0000796494,0.0001460338,0.006747858,0.7340543,0.0002025211,0.2422062,0.0003047409],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795439,0.0006779185,0.001382735,0.007363692,0.0001405705,0.000969506,0.00006420157,0.00004630704,0.009811171],"genre_scores_gemma":[0.9953141,0.00008672178,0.002119192,0.001022231,0.0001092703,0.00004580676,0.00004866428,0.00002974882,0.001224305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2255687,"threshold_uncertainty_score":0.9999542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4231741136","doi":"10.2165/00128413-200615540-00012","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Synthesis of β-Lactam Compounds","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ezetimibe; Atorvastatin; Medicine; Pharmacy; Pharmacology; Family medicine; Internal medicine; Statin","retraction":null,"screen_n_in":null,"score":{"opus":0.04707652281454486,"gpt":0.2926426875188345,"spread":0.2455661647042896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001653376,0.0002056057,0.0002148072,0.00007988771,0.00005980624,0.0000421316,0.0003365786,0.00005710597,0.0006596734],"category_scores_gemma":[0.0002494604,0.0002286826,0.00005937308,0.0001563704,0.00001540191,0.0001459479,0.00004430815,0.0001470856,0.00006550591],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001097059,"about_ca_system_score_gemma":0.0005528099,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4229904,"about_ca_topic_score_gemma":0.4693349,"domain_scores_codex":[0.9984373,0.00002295645,0.000366089,0.000382382,0.0003740367,0.0004172279],"domain_scores_gemma":[0.9985476,0.0008276756,0.0001008135,0.000329636,0.00007494241,0.0001194008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001118948,0.000257892,0.06167303,0.0003795026,0.00003927786,0.0001213858,0.000166024,0.00461005,0.4152713,0.0001795478,0.4803899,0.03579306],"study_design_scores_gemma":[0.002427562,0.0001095242,0.05244626,0.001114383,0.00004910874,0.000020077,0.0004367958,0.003672411,0.7690167,0.0003401176,0.1692132,0.001153921],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911389,0.0001204799,0.00009343143,0.002291563,0.0002259584,0.0001994458,0.00006575277,0.00006513998,0.005799337],"genre_scores_gemma":[0.9963565,0.000005225046,0.001343598,0.0007594223,0.0003861234,0.0001596018,0.00001774513,0.00004150741,0.0009302435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3537453,"threshold_uncertainty_score":0.9325405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248712378","doi":"10.2165/00128413-200515060-00051","title":"Safety updates to Canadian labelling for Duragesic","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Labelling; Medicine; Pharmacy; Medical emergency; Family medicine; Criminology; Psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.02394607577086246,"gpt":0.3393357333737358,"spread":0.3153896576028734,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001077183,0.0001304278,0.0001984666,0.00015342,0.000117502,0.00001276448,0.00007587857,0.0000535764,0.0018451],"category_scores_gemma":[0.00001771955,0.0001227779,0.00007110157,0.0001497668,0.00001735895,0.00006056397,0.0000119977,0.00009599852,0.0005105571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004017138,"about_ca_system_score_gemma":0.0002867157,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.006807869,"about_ca_topic_score_gemma":0.02552379,"domain_scores_codex":[0.9991198,0.00001270632,0.0001804714,0.0002117146,0.00007995604,0.0003954086],"domain_scores_gemma":[0.9992224,0.0000625953,0.00002561306,0.0001232869,0.00008066996,0.0004854578],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001374979,0.0002582058,0.004658309,0.00007635741,0.0003237009,0.0001042228,0.0008582624,0.0002799914,0.04311016,0.0003369931,0.8433759,0.105243],"study_design_scores_gemma":[0.002906062,0.0002420734,0.002279253,0.00001876273,0.0001583689,0.00002943339,0.00002563821,0.0003415481,0.02560659,0.00002369632,0.9682364,0.0001321076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7354955,0.001593128,0.0003331518,0.2380228,0.001120442,0.002267177,0.0003426998,0.0001850757,0.02063999],"genre_scores_gemma":[0.961655,0.00008636121,0.002362402,0.02247661,0.001315806,0.0001239874,0.0001153538,0.00003250989,0.01183196],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2261595,"threshold_uncertainty_score":0.9998059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4244309416","doi":"10.2165/00128413-200615400-00068","title":"Auxilium Pharmaceuticals has received marketing approval from Health Canada for its topical testosterone gel","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Immunotoxicology and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Drug approval; Family medicine; Pharmacology; Marketing; Drug; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.03935785095437948,"gpt":0.2892082049520718,"spread":0.2498503539976923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007460424,0.0003303664,0.0005667384,0.00008236927,0.0007283971,0.00003824857,0.0004027442,0.0003071706,0.001030055],"category_scores_gemma":[0.0004467545,0.0003204296,0.0001281441,0.0001200442,0.000268258,0.0001197331,0.0001271067,0.000569345,0.0001377111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002354775,"about_ca_system_score_gemma":0.001474987,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0648453,"about_ca_topic_score_gemma":0.02295791,"domain_scores_codex":[0.9968388,0.0009312681,0.0007141574,0.0005139088,0.00007268122,0.0009291529],"domain_scores_gemma":[0.9976017,0.001674873,0.000234409,0.000300445,0.0001306257,0.00005798891],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003280205,0.0002877776,0.0009171842,0.00006101398,0.0002539948,0.00002100853,0.0001057908,0.000007507476,0.7645196,0.0000882474,0.218143,0.01231462],"study_design_scores_gemma":[0.004616654,0.0002388915,0.02645711,0.00005151285,0.00006789419,0.00007338743,0.000172769,0.00006355466,0.28304,0.00005850478,0.6847754,0.0003843675],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9486101,0.02431577,0.0002554689,0.02118455,0.003201011,0.001146261,0.0004803609,0.0001564499,0.0006499992],"genre_scores_gemma":[0.9857367,0.00008849293,0.0003259296,0.00366432,0.0002488845,0.00008160459,0.0005321155,0.00004108295,0.009280905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4814797,"threshold_uncertainty_score":0.9999248,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4212882070","doi":"10.2165/00128413-200715910-00071","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.3321649356588049,"gpt":0.4240665891210503,"spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01640483,0.000167804,0.0006642546,0.000308317,0.00007595725,0.00003242992,0.0003065425,0.00005483615,0.0006116093],"category_scores_gemma":[0.001525328,0.0002274048,0.00005276305,0.000325812,0.00002987733,0.0003223889,0.00004207018,0.0002275705,0.001219243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002128053,"about_ca_system_score_gemma":0.0009342765,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8150342,"about_ca_topic_score_gemma":0.7832496,"domain_scores_codex":[0.9952229,0.0001178308,0.003402739,0.0005371569,0.0001093284,0.0006100148],"domain_scores_gemma":[0.9978288,0.0005084057,0.000994819,0.0004217707,0.000040514,0.0002057325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004309632,0.000156504,0.7066765,0.0004024755,0.00006364733,0.00004261186,0.001600654,0.000403295,0.00006227985,0.02634399,0.2609862,0.003218716],"study_design_scores_gemma":[0.001609937,0.00003372633,0.4703625,0.00006401195,0.000003938244,0.00002001687,0.001793831,0.001720971,0.0003434292,0.004827613,0.5184979,0.0007221243],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9247591,0.002519448,0.0008907468,0.04363343,0.001801735,0.0008817166,0.0001341174,0.0000504421,0.02532922],"genre_scores_gemma":[0.9835208,0.00003324832,0.0009784997,0.01385069,0.0004959002,0.00004341995,0.0000155878,0.00003032805,0.001031535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2575117,"threshold_uncertainty_score":0.9995584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4254352082","doi":"10.2165/00128413-200816570-00002","title":"The 2008 clinical type 2 diabetes guidelines from the Canadian Diabetes Association (CDA) include the new class of DPP-IV* inhibitors.","year":2008,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology; Drug","retraction":null,"screen_n_in":null,"score":{"opus":0.05587108759421896,"gpt":0.3279714595386067,"spread":0.2721003719443877,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00129198,0.0002451091,0.0004142401,0.00006061572,0.0006731324,0.0000675448,0.000455661,0.0001589364,0.0001312183],"category_scores_gemma":[0.001603985,0.0001220707,0.0002407175,0.000377514,0.0002583186,0.0001078248,0.0001549829,0.00037863,0.0001861051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002770172,"about_ca_system_score_gemma":0.0006495944,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01328348,"about_ca_topic_score_gemma":0.02446886,"domain_scores_codex":[0.9974491,0.0002492392,0.0007942953,0.000286765,0.0006481974,0.000572429],"domain_scores_gemma":[0.996801,0.001538957,0.0003745032,0.0006117979,0.0004076975,0.0002660934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001750613,0.00005221519,0.4152302,0.000004083225,0.0004821867,0.000004319903,0.0001537321,0.000004069672,0.0001464198,0.0000380571,0.5742449,0.009622326],"study_design_scores_gemma":[0.001351518,0.0002084369,0.3174401,0.00006372382,0.0004772244,3.63719e-7,0.00009887531,0.0003944746,0.001606618,0.0003105744,0.6779058,0.0001422563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8655581,0.005286896,9.429637e-7,0.1234094,0.001738926,0.0007529889,0.00004147935,0.00005901748,0.003152281],"genre_scores_gemma":[0.9754122,0.001865337,0.0001333711,0.01109632,0.00241137,0.00004045375,0.0001032538,0.00004077156,0.008896937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.112313,"threshold_uncertainty_score":0.993332,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4245182772","doi":"10.2165/00128413-200615530-00070","title":"Product approvals in Canada","year":2006,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine; Mathematics","retraction":null,"screen_n_in":null,"score":{"opus":0.2568913582669395,"gpt":0.3872280217158144,"spread":0.1303366634488748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005789684,0.0001688189,0.0006697429,0.0002338262,0.00007556228,0.00004422807,0.000278133,0.00004751089,0.0006214075],"category_scores_gemma":[0.0006347407,0.0002285916,0.00005363025,0.0002711494,0.00002826705,0.0003245206,0.00003658746,0.0001804597,0.001241178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001772428,"about_ca_system_score_gemma":0.0009563347,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9452356,"about_ca_topic_score_gemma":0.8103741,"domain_scores_codex":[0.9956675,0.0001623734,0.003053521,0.0005363763,0.00009765833,0.0004826032],"domain_scores_gemma":[0.9982247,0.0002813418,0.0009539333,0.000399866,0.00003469347,0.0001055194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001179782,0.0001160698,0.4653972,0.0002417838,0.00002399029,0.00001402351,0.0002562121,0.001493561,0.00003404288,0.0304244,0.5015379,0.0004489606],"study_design_scores_gemma":[0.0016003,0.00002366283,0.4310196,0.00005597331,0.000004124206,0.00001439573,0.0005219759,0.00486231,0.0001867856,0.01457091,0.5464289,0.0007110774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8978136,0.003191638,0.0002305778,0.06576224,0.001324911,0.000862056,0.0002504983,0.00005505134,0.03050946],"genre_scores_gemma":[0.9889086,0.00002259114,0.0006775231,0.007659049,0.0006095251,0.0001110283,0.00003414637,0.00003054147,0.001947034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1348614,"threshold_uncertainty_score":0.9995365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4245051009","doi":"10.2165/00128413-200514740-00048","title":"Health Canada has approved bortezomib [Velcade; Millennium Pharmaceuticals].","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Bortezomib; Pharmacy; Pharmacology; Family medicine; Oncology; Internal medicine; Multiple myeloma","retraction":null,"screen_n_in":null,"score":{"opus":0.2246281412208943,"gpt":0.51268809366099,"spread":0.2880599524400956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002869697,0.0003865474,0.0007408319,0.0001235541,0.001883538,0.00004051755,0.0004502408,0.0002782019,0.002613359],"category_scores_gemma":[0.0003558836,0.0003490497,0.00009496028,0.0003658478,0.00008067927,0.0003723143,0.000146054,0.002048163,0.001111065],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001283134,"about_ca_system_score_gemma":0.01027372,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6518264,"about_ca_topic_score_gemma":0.7125484,"domain_scores_codex":[0.992837,0.002501648,0.001586074,0.0006188462,0.0007372068,0.001719297],"domain_scores_gemma":[0.9958621,0.001297605,0.000751787,0.0005606549,0.0002611109,0.001266756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001127665,0.00008256388,0.003583317,0.0006249676,0.00006373013,0.00002223861,0.002303543,0.000009665969,0.0002842056,0.0004890336,0.9382125,0.05421152],"study_design_scores_gemma":[0.001635103,0.00006178839,0.00369137,0.0001572974,0.00002033125,0.00001827491,0.002062452,0.0006452876,0.0001139688,0.00001072255,0.9912406,0.000342856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.04407544,0.01164467,0.0002201686,0.8805992,0.006378014,0.003200171,0.0003713814,0.0004656031,0.05304535],"genre_scores_gemma":[0.9073851,0.0009675244,0.0007338816,0.07760851,0.003595707,0.000275004,0.00004812172,0.00008865047,0.009297472],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.8633097,"threshold_uncertainty_score":0.9998962,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239662282","doi":"10.2165/00128413-200716170-00054","title":"Product approvals in Canada","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Pharmacy; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3321649356588049,"gpt":0.4240665891210503,"spread":0.09190165346224544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01640483,0.000167804,0.0006642546,0.000308317,0.00007595725,0.00003242992,0.0003065425,0.00005483615,0.0006116093],"category_scores_gemma":[0.001525328,0.0002274048,0.00005276305,0.000325812,0.00002987733,0.0003223889,0.00004207018,0.0002275705,0.001219243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002128053,"about_ca_system_score_gemma":0.0009342765,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8150342,"about_ca_topic_score_gemma":0.7832496,"domain_scores_codex":[0.9952229,0.0001178308,0.003402739,0.0005371569,0.0001093284,0.0006100148],"domain_scores_gemma":[0.9978288,0.0005084057,0.000994819,0.0004217707,0.000040514,0.0002057325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004309632,0.000156504,0.7066765,0.0004024755,0.00006364733,0.00004261186,0.001600654,0.000403295,0.00006227985,0.02634399,0.2609862,0.003218716],"study_design_scores_gemma":[0.001609937,0.00003372633,0.4703625,0.00006401195,0.000003938244,0.00002001687,0.001793831,0.001720971,0.0003434292,0.004827613,0.5184979,0.0007221243],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9247591,0.002519448,0.0008907468,0.04363343,0.001801735,0.0008817166,0.0001341174,0.0000504421,0.02532922],"genre_scores_gemma":[0.9835208,0.00003324832,0.0009784997,0.01385069,0.0004959002,0.00004341995,0.0000155878,0.00003032805,0.001031535],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2575117,"threshold_uncertainty_score":0.9995584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239001268","doi":"10.2165/00128413-200113090-00057","title":"Market news from Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.02023096354187482,"gpt":0.2872669464453149,"spread":0.2670359829034401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009303779,0.00006200515,0.00008257804,0.00001476434,0.0005768953,0.00003930945,0.0001263484,0.00003059873,0.004470489],"category_scores_gemma":[0.00004936588,0.00005548634,0.00003320683,0.0001857351,0.00008438156,0.00009731181,0.00003087503,0.00006919883,0.00003505062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001404734,"about_ca_system_score_gemma":0.0004369036,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9844975,"about_ca_topic_score_gemma":0.9883373,"domain_scores_codex":[0.9991979,0.00007015377,0.0001045387,0.0001240903,0.0002692686,0.0002340529],"domain_scores_gemma":[0.9996107,0.00009307661,0.00003209422,0.00009361375,0.00004979712,0.0001207368],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001087037,0.00001447549,0.01863245,7.950163e-7,0.00002514902,0.00007492799,0.001599221,0.000005396386,0.00003037807,0.0006955842,0.9695438,0.009367026],"study_design_scores_gemma":[0.0001434182,0.0000032747,0.03073616,0.000002955601,0.000009798875,7.237895e-7,0.002865239,0.00002162441,0.000008693954,0.0002861652,0.9658397,0.00008228543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.2992137,0.0004612325,0.00001959748,0.04643136,0.001327483,0.0001251128,0.00004696603,0.00005681752,0.6523178],"genre_scores_gemma":[0.969204,0.0002571795,0.00006831199,0.001495505,0.001081809,0.000006430618,0.000005280822,0.000005970487,0.02787552],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6699903,"threshold_uncertainty_score":0.9964396,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4235394295","doi":"10.2165/00128413-200313800-00057","title":"Market news from Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Advertising; Family medicine; Business","retraction":null,"screen_n_in":null,"score":{"opus":0.01773726546594473,"gpt":0.2777824235633968,"spread":0.2600451580974521,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001300232,0.00006156683,0.00008125727,0.00001278268,0.000565757,0.00003572169,0.00009252621,0.00003022132,0.004132246],"category_scores_gemma":[0.0001154408,0.00005527898,0.00003229732,0.0001557866,0.00008144347,0.00007878713,0.00001431142,0.00006838338,0.00002662275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000133076,"about_ca_system_score_gemma":0.000669878,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9572387,"about_ca_topic_score_gemma":0.9715007,"domain_scores_codex":[0.9991728,0.0001305849,0.000101534,0.0001223093,0.0002501254,0.0002226238],"domain_scores_gemma":[0.9996094,0.0001038026,0.00003139767,0.00009173442,0.00004760557,0.0001160579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003918699,0.00001466467,0.008064969,0.000001228014,0.00002739738,0.00002684183,0.001694729,0.000004891505,0.00003703446,0.00669035,0.9812073,0.002226717],"study_design_scores_gemma":[0.0001436628,0.000002836184,0.007817276,0.000002390447,0.000009823361,3.588888e-7,0.003432686,0.000004994579,0.00004930448,0.0005842334,0.9878684,0.0000840336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.1268813,0.000559505,0.00002071389,0.01442141,0.001593154,0.0001300103,0.000048664,0.00004106652,0.8563042],"genre_scores_gemma":[0.9790608,0.00008270302,0.0001545818,0.001138902,0.0003820402,0.000006578204,0.000002791316,0.000005913799,0.01916564],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.8521795,"threshold_uncertainty_score":0.9967781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4241767819","doi":"10.2165/00128413-200313980-00049","title":"Health Canada has approved a new formulation of methylphenidate ['Concerta'; Janssen-Ortho Inc.] for use in children with ADHD","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Methylphenidate; Medicine; Pharmacy; Psychiatry; Family medicine; Pediatrics; Attention deficit hyperactivity disorder","retraction":null,"screen_n_in":null,"score":{"opus":0.07703450529964993,"gpt":0.3326952086648549,"spread":0.255660703365205,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002460182,0.0002011922,0.0004893931,0.0001417088,0.00006596375,0.00002044358,0.00006832625,0.00008432485,0.00006674472],"category_scores_gemma":[0.000174896,0.0001803963,0.00006021894,0.0003454573,0.00003202002,0.0003070662,0.00001281326,0.000257541,0.000002130669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002053089,"about_ca_system_score_gemma":0.002634761,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4388747,"about_ca_topic_score_gemma":0.4194895,"domain_scores_codex":[0.9984471,0.00008887464,0.0004637994,0.0003191971,0.0003312404,0.0003498485],"domain_scores_gemma":[0.9989656,0.0001233696,0.000283984,0.0002768669,0.0001506837,0.0001994591],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001300449,0.0007261263,0.9537125,0.0002832934,0.0004993742,0.000011834,0.001251012,0.001290355,0.005249049,0.0005262776,0.01520202,0.01994776],"study_design_scores_gemma":[0.04294597,0.001592564,0.8525183,0.0004249666,0.0004915995,0.0003577069,0.002810603,0.00593266,0.007824529,0.0001718402,0.08381267,0.001116605],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878411,0.000202037,0.005658822,0.004287128,0.00006076955,0.001736262,0.00006358406,0.00002792543,0.0001223723],"genre_scores_gemma":[0.9918341,0.00001304752,0.006222225,0.001132882,0.00003912986,0.00005011753,0.0001835214,0.00004389941,0.0004810675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1011942,"threshold_uncertainty_score":0.7356348,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4254520879","doi":"10.2165/00128413-200514750-00059","title":"Abbott Laboratories' lansoprazole [Prevacid] has been approved in Canada","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Lansoprazole; Pharmacy; Family medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2634522031329605,"gpt":0.3845236645862825,"spread":0.121071461453322,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005183524,0.0002469496,0.0008648125,0.0002397038,0.0001532515,0.0001067834,0.0004347539,0.0001204754,0.001098352],"category_scores_gemma":[0.0009464874,0.0003393469,0.00006309992,0.0004046118,0.00004923228,0.0006769437,0.00006394281,0.0003258462,0.002123112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002465304,"about_ca_system_score_gemma":0.001798348,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6653524,"about_ca_topic_score_gemma":0.808669,"domain_scores_codex":[0.9953105,0.0001981337,0.003144666,0.0005809597,0.0001389197,0.0006267651],"domain_scores_gemma":[0.997704,0.0003988055,0.001037602,0.0005100726,0.00007568777,0.0002737948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004853144,0.0002224346,0.3787679,0.0003813511,0.0001192999,0.000020993,0.003633422,0.001859061,0.00007640458,0.0228466,0.5900062,0.002017811],"study_design_scores_gemma":[0.001569546,0.00002288192,0.053,0.0000385602,0.000004720082,0.000005227947,0.001033014,0.006998956,0.0001166194,0.001056029,0.9356567,0.0004977654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7783437,0.004619498,0.0005969518,0.1993318,0.001476837,0.001033358,0.001171569,0.0001092784,0.01331701],"genre_scores_gemma":[0.9722782,0.00008768141,0.001463947,0.02415165,0.0007658025,0.0001369934,0.0000529934,0.00004866711,0.001014031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3456505,"threshold_uncertainty_score":0.9999059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059851348","doi":"10.2165/00128413-200112810-00011","title":"Canada chooses its weapons in the battle against influenza","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Battle; Medicine; Virology; Ancient history; History","retraction":null,"screen_n_in":null,"score":{"opus":0.1052284051339479,"gpt":0.3876039190417949,"spread":0.282375513907847,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004274701,0.000198647,0.0002771231,0.0001478058,0.0001709156,0.00003390595,0.0003197906,0.00005353856,0.0003121503],"category_scores_gemma":[0.001034434,0.0001359128,0.00006038339,0.0006027654,0.00009445632,0.0001305823,0.0001054999,0.0005393595,0.0002128339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003046691,"about_ca_system_score_gemma":0.0009948259,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1534914,"about_ca_topic_score_gemma":0.1735744,"domain_scores_codex":[0.9979122,0.0001346116,0.0003283581,0.0002488333,0.0007545024,0.0006215017],"domain_scores_gemma":[0.9986894,0.0005759326,0.00005216469,0.0003619284,0.0001659797,0.0001546467],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009023196,0.0005178725,0.2009712,0.0002176276,0.0003008178,0.004313373,0.002129863,0.0002523659,0.01724445,0.0002428042,0.7552879,0.01761941],"study_design_scores_gemma":[0.001917005,0.00006309021,0.2075269,0.00006639352,0.00002094141,0.00004238765,0.0008443586,0.0001036624,0.001688469,0.000006870885,0.787568,0.0001518577],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9480634,0.002334958,0.000001345752,0.01384114,0.0002481164,0.0004994749,0.00004309728,0.00004411958,0.03492436],"genre_scores_gemma":[0.9721918,0.000624605,0.00002246802,0.02576218,0.0003327636,0.0001074576,0.000008257807,0.00002505402,0.0009254274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03399893,"threshold_uncertainty_score":0.8521456,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205152399","doi":"10.2165/00128413-200514830-00035","title":"Is it bye-bye Bextra in the US, EU and Canada?","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Infective Endocarditis Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02227963487045452,"gpt":0.3001602326206158,"spread":0.2778805977501613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002413587,0.0001208287,0.0001737846,0.0000585427,0.00006009056,0.00002587863,0.00008391227,0.00002817644,0.0005162728],"category_scores_gemma":[0.00003244151,0.00008833638,0.00004182725,0.00009726689,0.00003607952,0.00007547121,0.00003987625,0.0001831764,0.00003951016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001349162,"about_ca_system_score_gemma":0.00009754222,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.142989,"about_ca_topic_score_gemma":0.183,"domain_scores_codex":[0.9990658,0.00004979627,0.0001743168,0.000193495,0.0002688147,0.0002478408],"domain_scores_gemma":[0.9995971,0.0000780609,0.0000344733,0.0001826725,0.00003443314,0.00007321422],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001180601,0.0001229099,0.05962108,0.00003200449,0.00005912386,0.0002054943,0.0005592699,0.00001025893,0.0001185024,0.0004179984,0.9227356,0.01610592],"study_design_scores_gemma":[0.0009514942,0.00004413529,0.3419519,0.00002918119,0.00004348693,0.00003354898,0.0002261991,0.00008066601,0.0005505208,0.000009520416,0.6560046,0.00007472144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8666199,0.0006788812,0.00001663823,0.0735906,0.0002114623,0.0005175934,0.00002357105,0.00001721899,0.05832413],"genre_scores_gemma":[0.9280846,0.0004830751,0.00005702667,0.07048246,0.0003590544,0.00006266167,0.000007576133,0.00001169177,0.0004518355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2823309,"threshold_uncertainty_score":0.8627179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255248028","doi":"10.2165/00128413-200515060-00058","title":"Cetuximab [Erbitux; Bristol-Myers Squibb, ImClone Systems] injection has been approved by Health Canada's Biologics and Genetic Therapeutics Directorate","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Bristol-Myers; Cetuximab; Family medicine; Pharmacy; Pharmacology; Internal medicine; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.2486589550439336,"gpt":0.375657940229696,"spread":0.1269989851857624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004335925,0.0003635759,0.001176057,0.0002219335,0.0004973167,0.0002423455,0.0003085623,0.0001990605,0.0000584212],"category_scores_gemma":[0.0002401382,0.0004474508,0.00007452258,0.0002609031,0.0001394849,0.0003316333,0.00006528247,0.0003221336,0.000194844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002027163,"about_ca_system_score_gemma":0.0008571006,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3747374,"about_ca_topic_score_gemma":0.09191255,"domain_scores_codex":[0.9945278,0.0005490814,0.003252763,0.0007901181,0.0001502104,0.0007300121],"domain_scores_gemma":[0.9964825,0.0003761564,0.002201631,0.0004655775,0.00009469996,0.0003794708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000122864,0.0005325598,0.08712216,0.00147537,0.0006220493,0.000008625257,0.003286985,0.003831193,0.0004650271,0.002659844,0.8872188,0.01265448],"study_design_scores_gemma":[0.002081468,0.0002859916,0.01808863,0.00006888704,0.00002237504,0.00005410943,0.0009030132,0.03216196,0.00005522016,0.0002610369,0.9451971,0.0008201934],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7579746,0.06056487,0.004321105,0.1695308,0.002210804,0.002094382,0.002101061,0.0002340833,0.0009682692],"genre_scores_gemma":[0.9745799,0.001302935,0.001120333,0.02131985,0.000635733,0.0001252453,0.0001315229,0.00006901373,0.0007154814],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2828248,"threshold_uncertainty_score":0.9997977,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214588361","doi":"10.2165/00128413-200113140-00012","title":"Galantamine treatment for AD warranted in Canada","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Galantamine; Pharmacy; Psychiatry; Pharmacology; Family medicine; Internal medicine; Donepezil; Disease; Dementia","retraction":null,"screen_n_in":null,"score":{"opus":0.05737118821012451,"gpt":0.3357867796060424,"spread":0.2784155913959179,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005015378,0.0001408684,0.0002689145,0.00008788247,0.00003304191,0.000005798345,0.00004420704,0.00003421473,0.0005341835],"category_scores_gemma":[0.00004386767,0.0001231104,0.00006430553,0.0001817703,0.00001252167,0.00006328423,0.000008765615,0.00008239433,0.00003375181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006977484,"about_ca_system_score_gemma":0.0005308472,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3962303,"about_ca_topic_score_gemma":0.7110784,"domain_scores_codex":[0.9991068,0.00002053865,0.0002175609,0.0002099261,0.0001643725,0.0002807881],"domain_scores_gemma":[0.9995384,0.00008722543,0.00004669504,0.0001667722,0.00005866275,0.0001022407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002138853,0.001570752,0.8441579,0.000123375,0.0002644457,0.001424124,0.0003949102,0.0001244492,0.04402405,0.00001189972,0.01231422,0.09345106],"study_design_scores_gemma":[0.0251746,0.0007028065,0.6551053,0.0001227952,0.0002411433,0.0006492196,0.003007868,0.008699001,0.002696281,0.00001540232,0.3031083,0.000477284],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905087,0.0002869644,0.0001470742,0.007109371,0.0001808001,0.0006687419,0.00003327844,0.00003371134,0.001031402],"genre_scores_gemma":[0.9946059,0.0001458249,0.0001181038,0.0007361006,0.00006061781,0.0001165041,0.0000778986,0.00002536408,0.004113692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3148482,"threshold_uncertainty_score":0.6077903,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246404833","doi":"10.2165/00128413-200113070-00051","title":"Canadian market news","year":2001,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Legal case studies and regulations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02235360564488778,"gpt":0.3097431214401045,"spread":0.2873895157952167,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001821228,0.00005687701,0.00006681867,0.0000619321,0.0008906989,0.00005823564,0.0001203045,0.00004411504,0.00500613],"category_scores_gemma":[0.00004745314,0.00005251496,0.00004454954,0.0002905865,0.00009916184,0.0001286912,0.00001612664,0.00006961855,0.0002374407],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001923661,"about_ca_system_score_gemma":0.0003366922,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7221024,"about_ca_topic_score_gemma":0.9081203,"domain_scores_codex":[0.9992443,0.00006291694,0.00008734468,0.000109332,0.0001594365,0.0003367058],"domain_scores_gemma":[0.9995231,0.00003356849,0.00001995128,0.00008577111,0.00005636429,0.0002812437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000006540178,0.00001534135,0.0211481,0.00000162567,0.00001987323,0.00009978939,0.004265368,0.000004818529,0.0000132992,0.00789336,0.9467735,0.01975842],"study_design_scores_gemma":[0.0001039575,0.000005591364,0.01077667,0.000002547465,0.000006810139,0.00000309865,0.002318946,0.00002030072,0.00000176443,0.0003590949,0.9863224,0.00007883619],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.03592626,0.0002204664,0.000009543679,0.06322408,0.0006266235,0.0001226665,0.000009994393,0.00005294546,0.8998074],"genre_scores_gemma":[0.908626,0.000317042,0.00005817787,0.001561777,0.0007361156,0.000008241729,0.000002110374,0.000006442292,0.08868407],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.8726997,"threshold_uncertainty_score":0.9959034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4240272195","doi":"10.2165/00128413-200213470-00011","title":"IV heparin use higher among US vs Canadian neurologists","year":2002,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Heparin; Family medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.04457635898650299,"gpt":0.2568608283495297,"spread":0.2122844693630267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0001085199,0.0002210492,0.0003891438,0.0002196449,0.0001275273,0.00008356715,0.0001747351,0.0001086581,0.005445661],"category_scores_gemma":[0.00004636582,0.0002063834,0.0001109541,0.0002233857,0.00009963719,0.0001999562,0.00006803966,0.0002707684,0.001132006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001403733,"about_ca_system_score_gemma":0.00003740751,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1892096,"about_ca_topic_score_gemma":0.04192494,"domain_scores_codex":[0.998435,0.00005056341,0.0002646484,0.0003780938,0.000258943,0.0006127462],"domain_scores_gemma":[0.9987929,0.00004102176,0.00006529751,0.0004420852,0.00006109146,0.0005975604],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.00003087253,0.0004409779,0.413077,0.00004950016,0.0001483594,0.001682427,0.0001674408,0.00004552301,0.0001916018,0.000405064,0.5802174,0.003543829],"study_design_scores_gemma":[0.0006425087,0.000153586,0.6126273,0.00001719779,0.0001029375,0.00001378326,0.000003319364,0.0004079312,0.00007181157,0.000009948517,0.3858147,0.0001349738],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9483326,0.00020327,0.00000278746,0.01153122,0.0008063853,0.0005175541,0.00001490088,0.0001497563,0.03844151],"genre_scores_gemma":[0.9706847,0.0003187436,0.00007285793,0.01949057,0.0003441392,0.00005943463,0.00001715544,0.00004596214,0.008966448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1995503,"threshold_uncertainty_score":0.9996457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}